Inflammaging
Reviewed by Maurice Lichtenberg
Inflammaging describes the chronic, low-grade, sterile inflammation that develops with age in the absence of overt infection. It is characterised by often elevated baseline levels of pro-inflammatory mediators such as IL-6, TNF-alpha and CRP, driven by senescent cells, accumulated cellular debris, gut dysbiosis and immune dysregulation. Inflammaging is a recognised hallmark of ageing and, in many studies, an independent risk factor associated with increased risk of cardiovascular disease, neurodegeneration, frailty, sarcopenia and overall mortality.
Sources
- Franceschi C, Bonafè M, Valensin S, et al.. (2000). Inflamm-aging: An evolutionary perspective on immunosenescence. *Annals of the New York Academy of Sciences*doi:10.1111/j.1749-6632.2000.tb06651.x
- Franceschi C, Campisi J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. *Journals of Gerontology A*doi:10.1093/gerona/glu057
